Clarithromycin
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Chinese University of Hong Kong
Overview
Clarithromycin is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Clarithromycin clinical trials
Explore related
Medical disclaimer. This page summarizes research about Clarithromycin for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.